Mehmet Oz Calls for Texas Hospice Fraud Probe, Expands Nationwide Medicaid Audit

Why It Matters

Medicaid and Medicare together fund the health care of the nation’s most vulnerable populations, and hospice services represent a growing slice of those expenditures. By targeting Texas—a state with the third‑largest elderly population and over 4.7 million Medicare beneficiaries—Oz’s probe could recover billions in misallocated funds and deter future schemes. The nationwide audit requirement also forces states to adopt uniform fraud‑detection standards, potentially reducing the patchwork of oversight that has allowed large‑scale abuse to persist. If successful, the initiative could set a precedent for federal‑state collaboration on other “soft services” that have historically evaded scrutiny, such as home‑health aides and specialty care centers. Conversely, pushback from state officials who view the move as federal overreach could spark legal challenges, testing the balance of power in Medicaid administration.

Key Takeaways

• CMS Administrator Mehmet Oz announced a Texas hospice fraud investigation after a Los Angeles task force shut down 450 hospices and paused $600 million in payments.
• Texas hospice licenses rose to 1,366 by March 2026, nearly doubling since 2020.
• A nationwide audit mandate gives each state 30 days to submit a plan for reviewing hospice and other soft‑service providers.
• Vice President JD Vance leads the anti‑fraud task force that coordinated the California shutdowns.
• Oz warned that fraud in “soft services” is difficult to detect under current CMS audit structures.

Pulse Analysis

Oz’s aggressive stance on hospice fraud reflects a broader shift in CMS strategy: moving from reactive investigations to proactive, data‑driven oversight. The Los Angeles shutdown demonstrated that concentrated enforcement can quickly disrupt entrenched networks, but it also exposed the limitations of existing audit tools. By mandating state‑level audit plans, CMS is effectively outsourcing the heavy lifting while retaining the authority to intervene when red flags emerge. This hybrid model could accelerate fraud detection without overburdening federal resources.

Historically, Medicaid fraud investigations have focused on more visible services—hospital billing, pharmacy claims, and durable medical equipment. Hospice, by contrast, operates under a “soft services” umbrella where services are often intangible and documentation sparse. Oz’s acknowledgment that “CMS was built and designed to audit per the operation” underscores a structural mismatch that the new audit framework seeks to address. If states adopt robust verification processes—such as mandatory background checks for hospice operators and real‑time utilization monitoring—the federal agency can leverage those data streams to pinpoint high‑risk providers.

Politically, the move may inflame tensions with states that view federal oversight as encroachment. Texas officials have already pushed back on CHIP reforms, and a similar backlash could arise around hospice audits. However, the financial stakes are enormous: even a modest reduction in fraudulent payouts could free up billions for legitimate patient care. The success of Oz’s initiative will hinge on the willingness of state Medicaid agencies to cooperate, the effectiveness of the audit templates, and the ability of CMS to act swiftly on the findings. In the short term, the Texas probe will serve as a litmus test for the broader audit program’s viability.